News

A major international study has uncovered three molecules that have the potential to be developed into new drugs to treat epilepsy. The findings are an important step towards discovering new drugs for people with epilepsy whose seizures cannot be controlled with current treatments.

Researchers have developed a novel method for extracting enzymes from bacteria, which could open up a new avenue for the enzymatic production of biodiesel.

Acute lymphoblastic leukemia (ALL) is the most common cancer in children. There are two types– B-ALL and T-ALL. It is known that the drug nelarabine is effective against T-ALL but not against B-ALL, however, until now the reason why was unknown. The new research study reveals the reason why and it involves the enzyme “SAMHD1”.

A group of scientists are looking to the microbiome of an Antarctic ascidian called Synoicum adareanum to better understand the possibilities for the development of a melanoma-specific drug.

New research has found that the feed additive 3-NOP can enteric methane emissions without affecting dry matter intake or milk yield of dairy cows.

Invasive fire ants common in the Gulf Coast and Texas likely are limiting a tick-acquired meat allergy in these areas, scientists report, but their bite can also cause a severe allergic reaction.

A food-grade variety of wheatgrass, an eco-friendly, cost-effective crop, and a popular superfood, has been released for public use.

Researchers have shown that the involvement of certain genes that predispose to cancer can also affect the immune system, which could facilitate tumor growth.

New research has identified mutations in a gene that interacts with several known autism spectrum disorder (ASD) genes, opening new research avenues for the condition.

Researchers have developed a method to spur the production of new antibiotic or antiparasitic compounds hiding in the genomes of actinobacteria, which are the source of drugs such as actinomycin and streptomycin and are known to harbor other untapped chemical riches.